title: Re: "Rifampin and linezolid in the treatment of methicillin-resistant Staphylococcus aureus preseptal cellulitis".
authors.forename: Leonardo
authors.initials: L
authors.lastname: Pagani
authors.forename: Claudio
authors.initials: C
authors.lastname: Vedovelli
authors.forename: Stefano
authors.initials: S
authors.lastname: Coser
authors.forename: Peter
authors.initials: P
authors.lastname: Mian
mesh_terms: D000081:Acetamides / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015818:Eye Infections, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D000069349:Linezolid; D055624:Methicillin-Resistant Staphylococcus aureus; D054517:Orbital Cellulitis / Q000188:drug therapy* / Q000382:microbiology; D023303:Oxazolidinones / Q000627:therapeutic use*; D019233:Retreatment; D012293:Rifampin / Q000627:therapeutic use*; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D000069349:Linezolid; D012293:Rifampin